0078-0958 : Kymriah 60000000 1/1 Intravenous Injection, Suspension


NDC: 0078-0958
Labeler: Novartis Pharmaceuticals Corporation
Product Type: Cellular Therapy
Drug Name: Kymriah
Dosage Form: Intravenous Injection, Suspension
Application #: BLA125646
Rev. Date: 


NDC Package Codes:

  • 0078-0958-19: 1 INJECTION, SUSPENSION IN 1 BAG (0078‑0958‑19)

Active Ingredients:

  • Tisagenlecleucel

Dosage Strength:

  • 60000000 1/1

Pharmaceutical Classes:

  • CD19-directed Chimeric Antigen Receptor [EPC]
  • Genetically-modified Autologous T Cells [EPC]
  • CD19 Receptor Interactions [MoA]
  • T Lymphocytes
  • Cultured
  • Autologous
  • Genetically-modified [EXT]

Related Products:

Based on records with the same trade name.
  • 0078-0846 Kymriah 2000000 1/1 Intravenous Injection, Suspension by Novartis Pharmaceuticals Corporation

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0078-0958 QR Code

< Prev: 0078-0953Next: 0078-0965 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.